-
Agostini ML, Andres EL, Sims AC, Graham RL, Sheahan TP, Lu X, Smith EC, Case JB, Feng JY, Jordan R, Ray AS, Cihlar T, Siegel D, Mackman RL, Clarke MO, Baric RS, Denison MR, 2018: Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease[J]. mBio, 9, e00221-18.
-
Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, Hohmann E, Chu HY, Luetkemeyer A, Kline S, Lopez de Castilla D, Finberg RW, Dierberg K, Tapson V, Hsieh L, Patterson TF, Paredes R, Sweeney DA, Short WR, Touloumi G, Lye DC, Ohmagari N, Oh MD, Ruiz-Palacios GM, Benfield T, Fatkenheuer G, Kortepeter MG, Atmar RL, Creech CB, Lundgren J, Babiker AG, Pett S, Neaton JD, Burgess TH, Bonnett T, Green M, Makowski M, Osinusi A, Nayak S, Lane HC, Members A-SG, 2020: Remdesivir for the treatment of Covid-19—final report[J]. N Engl J Med, 383, 1813-1826. doi: 10.1056/NEJMoa2007764
-
Brown AJ, Won JJ, Graham RL, Dinnon KH 3rd, Sims AC, Feng JY, Cihlar T, Denison MR, Baric RS, Sheahan TP, 2019: Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase[J]. Antiviral Res, 169, 104541-. doi: 10.1016/j.antiviral.2019.104541
-
Cho A, Saunders OL, Butler T, Zhang L, Xu J, Vela JE, Feng JY, Ray AS, Kim CU, 2012: Synthesis and antiviral activity of a series of 1′-substituted 4-aza-7,9-dideazaadenosine C-nucleosides[J]. Bioorg Med Chem Lett, 22, 2705-2707. doi: 10.1016/j.bmcl.2012.02.105
-
Cho HM, Ha TK, Dang LH, Pham HT, Tran VO, Huh J, An JP, Oh WK, 2019: Prenylated phenolic compounds from the leaves of Sabia limoniacea and their antiviral activities against porcine epidemic diarrhea virus[J]. J Nat Prod, 82, 702-713. doi: 10.1021/acs.jnatprod.8b00435
-
Fan Q, Zhang B, Ma J, Zhang S, 2020: Safety profile of the antiviral drug remdesivir: an update[J]. Biomed Pharmacother, 130, 110532-. doi: 10.1016/j.biopha.2020.110532
-
Fox JJ, Van Praag D, Wempen I, Doerr IL, Cheong L, Knoll JE, Eidinoff ML, Bendich A, Brown GB, 1959: Thiation of nucleosides. II. Synthesis of 5-methyl-2′-deoxycytidine and related pyrimidine nucleosides[J]. J Am Chem Soc, 81, 178-187. doi: 10.1021/ja01510a042
-
Goldman JD, Lye DCB, Hui DS, Marks KM, Bruno R, Montejano R, Spinner CD, Galli M, Ahn MY, Nahass RG, Chen YS, SenGupta D, Hyland RH, Osinusi AO, Cao H, Blair C, Wei X, Gaggar A, Brainard DM, Towner WJ, Munoz J, Mullane KM, Marty FM, Tashima KT, Diaz G, Subramanian A, 2020: Remdesivir for 5 or 10 days in patients with severe Covid-19[J]. N Engl J Med, 383, 1827-1837. doi: 10.1056/NEJMoa2015301
-
Gong L, Lin Y, Qin J, Li Q, Xue C, Cao Y, 2018: Neutralizing antibodies against porcine epidemic diarrhea virus block virus attachment and internalization[J]. Viro J, 15, 133-. doi: 10.1186/s12985-018-1042-3
-
Huan CC, Wang HX, Sheng XX, Wang R, Wang X, Mao X, 2017: Glycyrrhizin inhibits porcine epidemic diarrhea virus infection and attenuates the proinflammatory responses by inhibition of high mobility group box-1 protein[J]. Arch Virol, 162, 1467-1476. doi: 10.1007/s00705-017-3259-7
-
Jordheim LP, Durantel D, Zoulim F, Dumontet C, 2013: Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases[J]. Nat Rev Drug Discov, 12, 447-464. doi: 10.1038/nrd4010
-
Lee C, 2015: Porcine epidemic diarrhea virus: an emerging and re-emerging epizootic swine virus[J]. Virol J, 12, 193-. doi: 10.1186/s12985-015-0421-2
-
Li Y, Wu Q, Jin Y, Yang Q, 2019: Antiviral activity of interleukin-11 as a response to porcine epidemic diarrhea virus infection[J]. Vet Res, 50, 111-. doi: 10.1186/s13567-019-0729-9
-
Ma Y, Zhang Y, Liang X, Lou F, Oglesbee M, Krakowka S, Li J, 2015: Origin, evolution, and virulence of porcine deltacoronaviruses in the United States[J]. mBio, 6, e00064-.
-
Mehellou Y, Rattan HS, Balzarini J, 2018: The ProTide Prodrug Technology: from the concept to the clinic[J]. J Med Chem, 61, 2211-2226. doi: 10.1021/acs.jmedchem.7b00734
-
Murakami E, Tolstykh T, Bao H, Niu C, Steuer HM, Bao D, Chang W, Espiritu C, Bansal S, Lam AM, Otto MJ, Sofia MJ, Furman PA, 2010: Mechanism of activation of PSI-7851 and its diastereoisomer PSI-7977[J]. J Biol Chem, 285, 34337-34347. doi: 10.1074/jbc.M110.161802
-
Murphy BG, Perron M, Murakami E, Bauer K, Park Y, Eckstrand C, Liepnieks M, Pedersen NC, 2018: The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies[J]. Vet Microbiol, 219, 226-233. doi: 10.1016/j.vetmic.2018.04.026
-
Painter WP, Holman W, Bush JA, Almazedi F, Malik H, Eraut NCJE, Morin MJ, Szewczyk LJ, Painter GR, 2020: Human safety, tolerability, and pharmacokinetics of a novel broad-spectrum oral antiviral compound, molnupiravir, with activity against SARS-CoV-2[J]. medRxiv, , 1-32.
-
Pruijssers AJ, George AS, Schafer A, Leist SR, Gralinksi LE, Dinnon KH 3rd, Yount BL, Agostini ML, Stevens LJ, Chappell JD, Lu X, Hughes TM, Gully K, Martinez DR, Brown AJ, Graham RL, Perry JK, Du Pont V, Pitts J, Ma B, Babusis D, Murakami E, Feng JY, Bilello JP, Porter DP, Cihlar T, Baric RS, Denison MR, Sheahan TP, 2020: Remdesivir inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice[J]. Cell Rep, 32, 107940-. doi: 10.1016/j.celrep.2020.107940
-
Purohit MK, Poduch E, Wei LW, Crandall IE, To T, Kain KC, Pai EF, Kotra LP, 2012: Novel cytidine-based orotidine-5′-monophosphate decarboxylase inhibitors with an unusual twist[J]. J Med Chem, 55, 9988-9997. doi: 10.1021/jm301176r
-
Seley-Radtke KL, Yates MK, 2018: The evolution of nucleoside analogue antivirals: a review for chemists and non-chemists. Part 1: early structural modifications to the nucleoside scaffold[J]. Antiviral Res, 154, 66-86. doi: 10.1016/j.antiviral.2018.04.004
-
Sheahan TP, Sims AC, Graham RL, Menachery VD, Gralinski LE, Case JB, Leist SR, Pyrc K, Feng JY, Trantcheva I, Bannister R, Park Y, Babusis D, Clarke MO, Mackman RL, Spahn JE, Palmiotti CA, Siegel D, Ray AS, Cihlar T, Jordan R, Denison MR, Baric RS, 2017: Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses[J]. Sci Transl Med, 9, eaal3653-. doi: 10.1126/scitranslmed.aal3653
-
Sheahan TP, Sims AC, Leist SR, Schafer A, Won J, Brown AJ, Montgomery SA, Hogg A, Babusis D, Clarke MO, Spahn JE, Bauer L, Sellers S, Porter D, Feng JY, Cihlar T, Jordan R, Denison MR, Baric RS, 2020a: Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV[J]. Nat Commun, 11, 222-. doi: 10.1038/s41467-019-13940-6
-
Sheahan TP, Sims AC, Zhou S, Graham RL, Pruijssers AJ, Agostini ML, Leist SR, Schafer A, Dinnon KH 3rd, Stevens LJ, Chappell JD, Lu X, Hughes TM, George AS, Hill CS, Montgomery SA, Brown AJ, Bluemling GR, Natchus MG, Saindane M, Kolykhalov AA, Painter G, Harcourt J, Tamin A, Thornburg NJ, Swanstrom R, Denison MR, Baric RS, 2020b: An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice[J]. Sci Transl Med, 12, eabb5883-. doi: 10.1126/scitranslmed.abb5883
-
Siegel D, Hui HC, Doerffler E, Clarke MO, Chun K, Zhang L, Neville S, Carra E, Lew W, Ross B, Wang Q, Wolfe L, Jordan R, Soloveva V, Knox J, Perry J, Perron M, Stray KM, Barauskas O, Feng JY, Xu Y, Lee G, Rheingold AL, Ray AS, Bannister R, Strickley R, Swaminathan S, Lee WA, Bavari S, Cihlar T, Lo MK, Warren TK, Mackman RL, 2017: Discovery and synthesis of a phosphoramidate prodrug of a pyrrolo[2,1-f][triazin-4-amino] adenine C-nucleoside (GS-5734) for the treatment of Ebola and emerging viruses[J]. J Med Chem, 60, 1648-1661. doi: 10.1021/acs.jmedchem.6b01594
-
Spinner CD, Gottlieb RL, Criner GJ, Arribas Lopez JR, Cattelan AM, Soriano Viladomiu A, Ogbuagu O, Malhotra P, Mullane KM, Castagna A, Chai LYA, Roestenberg M, Tsang OTY, Bernasconi E, Le Turnier P, Chang SC, SenGupta D, Hyland RH, Osinusi AO, Cao H, Blair C, Wang H, Gaggar A, Brainard DM, McPhail MJ, Bhagani S, Ahn MY, Sanyal AJ, Huhn G, Marty FM, 2020: Effect of remdesivir vs standard care on clinical status at 11 days in patients with moderate COVID-19: a randomized clinical trial[J]. JAMA, 324, 1048-1057. doi: 10.1001/jama.2020.16349
-
Tong T, Hu H, Zhou J, Deng S, Zhang X, Tang W, Fang L, Xiao S, Liang J, 2020: Glycyrrhizic-acid-based carbon dots with high antiviral activity by multisite inhibition mechanisms[J]. Small, 16, e1906206-. doi: 10.1002/smll.201906206
-
Valencia DN, 2020: Brief review on COVID-19: the 2020 pandemic caused by SARS-CoV-2[J]. Cureus, 12, e7386-.
-
Wang Q, Vlasova AN, Kenney SP, Saif LJ, 2019: Emerging and re-emerging coronaviruses in pigs[J]. Curr Opin Virol, 34, 39-49. doi: 10.1016/j.coviro.2018.12.001
-
Warren TK, Jordan R, Lo MK, Ray AS, Mackman RL, Soloveva V, Siegel D, Perron M, Bannister R, Hui HC, Larson N, Strickley R, Wells J, Stuthman KS, Van Tongeren SA, Garza NL, Donnelly G, Shurtleff AC, Retterer CJ, Gharaibeh D, Zamani R, Kenny T, Eaton BP, Grimes E, Welch LS, Gomba L, Wilhelmsen CL, Nichols DK, Nuss JE, Nagle ER, Kugelman JR, Palacios G, Doerffler E, Neville S, Carra E, Clarke MO, Zhang L, Lew W, Ross B, Wang Q, Chun K, Wolfe L, Babusis D, Park Y, Stray KM, Trancheva I, Feng JY, Barauskas O, Xu Y, Wong P, Braun MR, Flint M, McMullan LK, Chen SS, Fearns R, Swaminathan S, Mayers DL, Spiropoulou CF, Lee WA, Nichol ST, Cihlar T, Bavari S, 2016: Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys[J]. Nature, 531, 381-385. doi: 10.1038/nature17180
-
Xu X, Liu Y, Weiss S, Arnold E, Sarafianos SG, Ding J, 2003: Molecular model of SARS coronavirus polymerase: implications for biochemical functions and drug design[J]. Nucleic Acids Res, 31, 7117-7130. doi: 10.1093/nar/gkg916
-
Yan VC, Muller FL, 2020: Advantages of the parent nucleoside GS-441524 over remdesivir for Covid-19 treatment[J]. ACS Med Chem Lett, 11, 1361-1366. doi: 10.1021/acsmedchemlett.0c00316
-
Yang JL, Ha TK, Dhodary B, Pyo E, Nguyen NH, Cho H, Kim E, Oh WK, 2015: Oleanane triterpenes from the flowers of Camellia japonica inhibit porcine epidemic diarrhea virus (PEDV) replication[J]. J Med Chem, 58, 1268-1280. doi: 10.1021/jm501567f
-
Yates MK, Seley-Radtke KL, 2019: The evolution of antiviral nucleoside analogues: a review for chemists and non-chemists[J]. Part Ⅱ: complex modifications to the nucleoside scaffold. Antiviral Res, 162, 5-21.
-
Ye G, Wang X, Tong X, Shi Y, Fu ZF, Peng G, 2020: Structural basis for inhibiting porcine epidemic diarrhea virus replication with the 3C-like protease inhibitor GC376[J]. Viruses, 12, 240-. doi: 10.3390/v12020240
-
Yoon JJ, Toots M, Lee S, Lee ME, Ludeke B, Luczo JM, Ganti K, Cox RM, Sticher ZM, Edpuganti V, Mitchell DG, Lockwood MA, Kolykhalov AA, Greninger AL, Moore ML, Painter GR, Lowen AC, Tompkins SM, Fearns R, Natchus MG, Plemper RK, 2018: Orally efficacious broad-spectrum ribonucleoside analog inhibitor of influenza and respiratory syncytial viruses[J]. Antimicrob Agents Chemother, 62, e00766-e818.
-
Zhang F, Chen Y, Ke Y, Zhang L, Zhang B, Yang L, Zhu J, 2019: Single Chain Fragment Variable (scFv) antibodies targeting the spike protein of porcine epidemic diarrhea virus provide protection against viral infection in piglets[J]. Viruses, 11, 58-. doi: 10.3390/v11010058
-
Zhao P, Wang B, Ji CM, Cong X, Wang M, Huang YW, 2018: Identification of a peptide derived from the heptad repeat 2 region of the porcine epidemic diarrhea virus (PEDV) spike glycoprotein that is capable of suppressing PEDV entry and inducing neutralizing antibodies[J]. Antiviral Res, 150, 1-8. doi: 10.1016/j.antiviral.2017.11.021